Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
43.72
-0.06 (-0.14%)
At close: Aug 14, 2026, 4:00 PM EDT
43.83
+0.11 (0.25%)
After-hours: Aug 14, 2026, 7:30 PM EDT

Sanofi Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Sanofi stock has a consensus rating of "Buy" and an average price target of $53.72. The average 1-year stock price forecast is 22.87% higher than the current stock price, while the lowest is $45 (+2.93%) and the highest is $63 (+44.10%).

Price Target: $53.72 (+22.87%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$45$53.72$54.5$63
Change+2.93%+22.87%+24.66%+44.10%
* Price targets were last updated on Jul 8, 2026.

Analyst Ratings

The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy444555
Buy321000
Hold345555
Sell000000
Strong Sell000000
Total101010101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Guggenheim
Guggenheim
Hold
Maintains
n/a
HoldMaintainsn/an/aJul 10, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
$52$49
HoldMaintains$52$49+12.08%Jul 8, 2026
TD Cowen
TD Cowen
Hold
Maintains
$57
HoldMaintains$57+30.38%Jun 29, 2026
Exane BNP Paribas
Exane BNP Paribas
Hold
Downgrades
$50
HoldDowngrades$50+14.36%Apr 20, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
47.51B
from 46.72B
Increased by 1.69%
Revenue Next Year
50.61B
from 47.51B
Increased by 6.53%
EPS This Year
8.57
from 7.83
Increased by 9.44%
EPS Next Year
9.05
from 8.57
Increased by 5.57%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
39.18B40.30B41.11B44.29B46.72B47.51B
Revenue Growth
4.83%2.88%2.00%7.73%5.49%1.69%
Gross Profit
26.92B28.44B28.49B31.09B33.79B36.18B
Gross Margin
68.73%70.55%69.30%70.21%72.34%76.16%
Operating Income
8.57B10.38B8.12B8.87B9.65B13.25B
Net Income
6.22B8.37B5.40B5.56B7.81B7.94B
EPS
----7.838.57
EPS Growth
----9.97%9.44%
Forward PE
-----8.82
Dividend / Share
3.333.563.763.924.124.25
Dividend Growth
4.06%6.91%5.62%4.26%5.10%3.26%
Free Cash Flow
7.34B8.51B7.17B-4.94B16.64B8.34B
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High48.1B
Avg47.5B
Low46.3B

Revenue Growth

Revenue Growth202620272028
High
3.1%
Avg
1.7%
Low
-0.8%

EPS Forecast

EPS202620272028
High8.96
Avg8.57
Low8.09

EPS Growth

EPS Growth202620272028
High
14.4%
Avg
9.4%
Low
3.3%